Lyratherapeutics
Founded 2018 · 25 employees on LinkedIn · 1 known investors
Lyra Therapeutics is a clinical-stage biotechnology company developing drug-eluting nasal meshes for localized treatment of chronic rhinosinusitis. The company's lead candidate delivers anti-inflammatory medication directly to sinonasal tissues for patients with this inflammatory disease.
Investors · 1
Founder mafia
2 people who came through Lyratherapeutics went on to found or lead other companies.
Frequently asked questions
- What does Lyratherapeutics do?
- Lyra Therapeutics is a clinical-stage biotechnology company developing drug-eluting nasal meshes for localized treatment of chronic rhinosinusitis. The company's lead candidate delivers anti-inflammatory medication directly to sinonasal tissues for patients with this inflammatory disease.
- Who are Lyratherapeutics's investors?
- Lyratherapeutics's investors include Broadview Ventures.